#United States #Shareholders #Cash Dividend #Quest Diagnostics #Secaucus

Quest Diagnostics Declares Quarterly Cash Dividend

Introduction
On August 12, 2026, Quest Diagnostics (NYSE: DGX), an industry leader in diagnostic information services, made headlines by announcing a new quarterly cash dividend. This announcement signifies the company's commitment to rewarding its shareholders while maintaining strong financial health.

Details of the Dividend
The Board of Directors at Quest Diagnostics has declared a cash dividend of $0.86 per share. This distribution is scheduled to be payable on October 21, 2026, thereby incentivizing shareholders of record as of October 6, 2026. Such consistent dividend payouts reflect the company’s robust operational performance and their ongoing strategy to enhance shareholder value.

About Quest Diagnostics
Quest Diagnostics is at the forefront of the healthcare sector, striving to create a healthier world through comprehensive diagnostic solutions. The company connects healthcare providers and consumers with invaluable laboratory insights that lead to better health outcomes. It plays a pivotal role in the healthcare ecosystem, serving nearly half of the physicians and hospitals across the United States, along with catering to one in three American adults every year.

With a team of approximately 60,000 employees, Quest Diagnostics is committed to delivering insightful diagnostics that prompt actionable steps to improve overall health management. Their focus on providing smarter and simpler testing options enables them to reveal new pathways in identifying and treating diseases.

Financial Performance and Outlook
The recent declaration of a dividend comes in tandem with Quest Diagnostics' ongoing momentum in financial performance. The company has demonstrated solid operational metrics, thus enhancing its earnings stability. Investors often view dividends as an affirmation of a company’s financial strength and a positive outlook regarding future profitability.

As the healthcare sector continues to evolve, Quest Diagnostics remains dedicated to its mission of empowering individuals with the necessary tools and knowledge to manage their health effectively. Through innovative testing solutions and a customer-centric approach, they are well-positioned to navigate future challenges and expand their impact within the diagnostic landscape.

Conclusion
In conclusion, Quest Diagnostics’ latest announcement regarding its quarterly cash dividend reinforces its longstanding tradition of delivering shareholder returns while fostering growth in the diagnostic field. The $0.86 dividend serves as an affirmation of the company’s commitment to its shareholders and its progressive approach to health services. As this respected company continues its pursuit of diagnostic excellence, stakeholders look forward to reaping the benefits of their investments.

Visit www.QuestDiagnostics.com for more information about their services and ongoing initiatives.